Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington's disease

@inproceedings{Stout2012EvaluationOL,
  title={Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington's disease},
  author={Julie C. Stout and Rebecca Jones and Izelle Labuschagne and A M O'regan and Miranda J Say and Eve M. Dumas and Sarah Queller and Damian Justo and Rachelle C Dar Santos and Allison J Coleman and Ellen P. Hart and Alexandra D{\"u}rr and Blair R. Leavitt and Raymund Roos and Doug R. Langbehn and Sarah J Tabrizi and Chris Frost},
  booktitle={Journal of neurology, neurosurgery, and psychiatry},
  year={2012}
}
BACKGROUND Deterioration of cognitive functioning is a debilitating symptom in many neurodegenerative diseases, such as Huntington's disease (HD). To date, there are no effective treatments for the cognitive problems associated with HD. Cognitive assessment outcomes will have a central role in the efforts to develop treatments to delay onset or slow the progression of the disease. The TRACK-HD study was designed to build a rational basis for the selection of cognitive outcomes for HD clinical… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 6 times over the past 90 days. VIEW TWEETS

From This Paper

Figures, tables, results, connections, and topics extracted from this paper.
46 Extracted Citations
15 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.
Showing 1-10 of 46 extracted citations

Referenced Papers

Publications referenced by this paper.
Showing 1-10 of 15 references

Similar Papers

Loading similar papers…